Research location

Blantyre

Malawi

Published trials67

Site observations73

Linked trials published67

Page1 / 2

Research activity in Blantyre

Malawi

CureCurrent currently publishes aggregate city-level research activity for this location: 67 trials and 73 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Blantyre

67 linked trials · page 1 of 2

BetterInfo on Women's PrEP Choices and Outcomes in MalawiNCT07579754 · 2026-07-14 · 1 site observation

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV RemissionNCT02140255 · 2015-01-23 · 1 site observation

A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)NCT07595042 · 2026-10-30 · 1 site observation

NOT_YET_RECRUITING

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVNCT06705478 · 2026-05-17 · 1 site observation

Pausing Antiretroviral Treatment Under Structured EvaluationNCT06031272 · 2024-05-28 · 1 site observation

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)NCT06134362 · 2024-05-14 · 1 site observation

ACTIVE_NOT_RECRUITING

Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource SettingsNCT04024488 · 2024-04-06 · 1 site observation

Enhancing Mental Health Outcomes for Patients With Psychosis in Malawi Through Community-based RehabilitationNCT06080477 · 2023-12-04 · 1 site observation

Experimental Pneumococcal Carriage in People Living With HIVNCT05698225 · 2023-01-01 · 1 site observation

Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of TuberculosisNCT05452616 · 2022-10-19 · 1 site observation

A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African WomenNCT05746065 · 2022-08-01 · 1 site observation

Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIVNCT05154513 · 2022-02-02 · 1 site observation

Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of ConcernNCT05168813 · 2021-12-01 · 1 site observation

Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST StudyNCT04311502 · 2021-11-05 · 1 site observation

Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP StudyNCT04860323 · 2021-05-28 · 1 site observation

B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-BNCT04193189 · 2020-12-14 · 1 site observation

Use of Mobile Phone Application for Asthma Sele ManagementNCT06900361 · 2020-11-11 · 1 site observation

Safety and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant PairsNCT04140266 · 2020-09-24 · 1 site observation

Neurodevelopmental Assessment of Children in Uganda and Malawi Using a Software PackageNCT03878147 · 2020-03-30 · 1 site observation

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe PneumoniaNCT03915366 · 2020-03-01 · 1 site observation

Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in PregnancyNCT03965923 · 2020-01-09 · 1 site observation

FujiLAM Prospective Evaluation TrialNCT04089423 · 2019-12-13 · 1 site observation

Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLDNCT04050449 · 2019-10-28 · 1 site observation

Group Antenatal Care: Effectiveness and Contextual Factors Linked to Implementation Success in MalawiNCT03673709 · 2019-07-05 · 7 site observations

WeMen! Improving Women's Access to Healthcare System Through Men's InclusionNCT04356157 · 2019-07-01 · 1 site observation

Achieving Control of Asthma in Children In AfricaNCT03990402 · 2019-05-16 · 1 site observation

Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis TherapyNCT03819114 · 2019-05-06 · 1 site observation

Rectal Microbicide Acceptability, Tolerability and AdherenceNCT03671239 · 2019-04-26 · 1 site observation

A Cluster Randomised Trial of Community-led Distribution of HIV Self-tests in Rural Malawi (HIV Self-Testing Africa [STAR])NCT03541382 · 2018-10-08 · 1 site observation

Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral TherapyNCT03208231 · 2018-08-06 · 1 site observation

Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and PostpartumNCT03386578 · 2018-07-03 · 1 site observation

Microbicide/PrEP Acceptability Among Mothers and Male Partners in AfricaNCT03648931 · 2018-05-31 · 1 site observation

A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in CryptosporidiosisNCT03341767 · 2017-12-14 · 1 site observation

Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected WomenNCT03164564 · 2017-11-07 · 1 site observation

ACTIVE_NOT_RECRUITING

Childhood Acute Illness and Nutrition NetworkNCT03208725 · 2016-11-30 · 1 site observation

Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in WomenNCT02858037 · 2016-07-18 · 1 site observation

Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected ChildrenNCT02426112 · 2016-06-01 · 1 site observation

HIV Self-Testing Africa (STAR) Malawi: General PopulationNCT02718274 · 2016-04-01 · 1 site observation

IMPAACT P1092: Steady State PK in Malnourished HIV Infected ChildrenNCT01818258 · 2015-10-26 · 1 site observation

Pilot Assessment of an Auto Blood Pressure MonitorNCT02258256 · 2015-03-01 · 1 site observation

Assessment of a Syringe Pump to Pre-eclamptic Women in a Low-resource HospitalNCT02296931 · 2015-03-01 · 1 site observation

Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-InfectedNCT01632891 · 2014-01-10 · 1 site observation

Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral TherapyNCT01825031 · 2013-06-01 · 1 site observation

Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in MalawiNCT01650558 · 2012-11-01 · 1 site observation

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)NCT01637558 · 2012-11-01 · 1 site observation

Chepetsa TB - Reducing TB Among HIV-Infected MalawiansNCT01450085 · 2012-09-01 · 1 site observation

Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in WomenNCT01617096 · 2012-07-24 · 1 site observation

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)NCT01404312 · 2012-05-23 · 1 site observation

HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected WomenNCT01315353 · 2012-04-04 · 1 site observation

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) TreatmentNCT01380080 · 2011-10-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.